Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1151

1.

Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.

Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, Suzuki T, Koda Y, Chu PS, Taniki N, Yamaguchi A, Kanamori M, Kamada N, Hattori M, Ashida H, Sakamoto M, Atarashi K, Narushima S, Yoshimura A, Honda K, Sato T, Kanai T.

Nat Microbiol. 2019 Jan 14. doi: 10.1038/s41564-018-0333-1. [Epub ahead of print]

PMID:
30643240
2.

GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump.

Schneditz G, Elias JE, Pagano E, Zaeem Cader M, Saveljeva S, Long K, Mukhopadhyay S, Arasteh M, Lawley TD, Dougan G, Bassett A, Karlsen TH, Kaser A, Kaneider NC.

Sci Signal. 2019 Jan 1;12(562). pii: eaau9048. doi: 10.1126/scisignal.aau9048.

PMID:
30600262
3.

Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.

Kumagai J, Taida T, Ogasawara S, Nakagawa T, Iino Y, Shingyoji A, Ishikawa K, Akizue N, Yamato M, Takahashi K, Ohta Y, Hamanaka S, Okimoto K, Nakamura M, Ohyama H, Saito K, Kusakabe Y, Maruoka D, Yasui S, Matsumura T, Sugiyama H, Sakai Y, Mikata R, Arai M, Katsuno T, Tsuyuguchi T, Kato N.

PLoS One. 2018 Dec 20;13(12):e0209352. doi: 10.1371/journal.pone.0209352. eCollection 2018.

4.

Interference with the lower gut-liver axis induces remission of primary sclerosing cholangitis in a patient with ulcerative colitis.

Ong J, Mebarek L, Bath M, Swift C, Javaid B, Patel J, Al-Naeeb Y.

BMJ Open Gastroenterol. 2018 Nov 14;5(1):e000239. doi: 10.1136/bmjgast-2018-000239. eCollection 2018.

5.

No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.

Mahmoud R, Shah SC, Ten Hove JR, Torres J, Mooiweer E, Castaneda D, Glass J, Elman J, Kumar A, Axelrad J, Ullman T, Colombel JF, Oldenburg B, Itzkowitz SH; Dutch initiative on Crohn and Colitis (ICC).

Gastroenterology. 2018 Dec 6. pii: S0016-5085(18)35386-1. doi: 10.1053/j.gastro.2018.11.067. [Epub ahead of print]

PMID:
30529584
6.

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.

Rosenzwajg M, Lorenzon R, Cacoub P, Pham HP, Pitoiset F, El Soufi K, RIbet C, Bernard C, Aractingi S, Banneville B, Beaugerie L, Berenbaum F, Champey J, Chazouilleres O, Corpechot C, Fautrel B, Mekinian A, Regnier E, Saadoun D, Salem JE, Sellam J, Seksik P, Daguenel-Nguyen A, Doppler V, Mariau J, Vicaut E, Klatzmann D.

Ann Rheum Dis. 2019 Feb;78(2):209-217. doi: 10.1136/annrheumdis-2018-214229. Epub 2018 Nov 24.

PMID:
30472651
7.

[PAPA syndrome with Crohn's disease and primary sclerosing cholangitis/autoimmune hepatitis overlap syndrome].

Schäffler H, Blattmann T, Findeisen A, Meinel FG, Meyer-Bahlburg A, Lamprecht G, Steinmüller-Magin L, Trauzeddel R, Emmert S.

Hautarzt. 2018 Nov 22. doi: 10.1007/s00105-018-4312-5. [Epub ahead of print] German.

PMID:
30467586
8.

Linear IgA Bullous Dermatosis Preceding the Diagnosis of Primary Sclerosing Cholangitis and Ulcerative Colitis: A Case Report.

Humphrey VS, Lee JJ, Supakorndej T, Malik SM, Huen AC, Jaroslaw J.

Am J Dermatopathol. 2018 Nov 15. doi: 10.1097/DAD.0000000000001313. [Epub ahead of print]

PMID:
30461424
9.

Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey.

Ünal NG, Özütemiz Ö, Tekin F, Turan İ, Osmanoğlu N.

Turk J Gastroenterol. 2018 Nov 20. doi: 10.5152/tjg.2018.18221. [Epub ahead of print]

PMID:
30460897
10.

Statin Use is Associated with Improved Outcomes of Patients With Primary Sclerosing Cholangitis.

Stokkeland K, Höijer J, Bottai M, Söderberg-Löfdal K, Bergquist A.

Clin Gastroenterol Hepatol. 2018 Nov 15. pii: S1542-3565(18)31245-X. doi: 10.1016/j.cgh.2018.11.002. [Epub ahead of print]

PMID:
30448601
11.

High serum sCD40 and a distinct colonic T-cell profile in ulcerative colitis associated with primary sclerosing cholangitis.

Lampinen M, Vessby J, Fredricsson A, Wanders A, Rorsman F, Carlson M.

J Crohns Colitis. 2018 Oct 20. doi: 10.1093/ecco-jcc/jjy170. [Epub ahead of print]

PMID:
30383225
12.

Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?

Galanopoulos M, Tsoukali E, Gkeros F, Vraka M, Karampekos G, Matzaris GJ.

World J Gastrointest Endosc. 2018 Oct 16;10(10):250-258. doi: 10.4253/wjge.v10.i10.250. Review.

13.

Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.

Samadder NJ, Valentine JF, Guthery S, Singh H, Bernstein CN, Leighton JA, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Burt RW, Curtin K, Smith KR.

Clin Gastroenterol Hepatol. 2018 Sep 26. pii: S1542-3565(18)31029-2. doi: 10.1016/j.cgh.2018.09.038. [Epub ahead of print]

PMID:
30267862
14.

PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis.

Bajer L, Wohl P, Drastich P.

Vnitr Lek. 2018 Summer;64(6):659-664.

PMID:
30223664
15.

Pediatric autoimmune liver disease and extra-hepatic immune-mediated comorbidities.

Paolella G, Farallo M, Degrassi I, Agostoni C, Amoruso C, Nuti F, Nebbia G.

Dig Liver Dis. 2018 Aug 3. pii: S1590-8658(18)30870-3. doi: 10.1016/j.dld.2018.07.033. [Epub ahead of print]

PMID:
30166220
16.

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.

Kruk B, Liebe R, Milkiewicz M, Wunsch E, Raszeja-Wyszomirska J, Lammert F, Milkiewicz P, Krawczyk M.

PLoS One. 2018 Aug 30;13(8):e0202942. doi: 10.1371/journal.pone.0202942. eCollection 2018.

17.
18.

Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.

Tan LZ, Reilly CR, Steward-Harrison LC, Balouch F, Muir R, Lewindon PJ.

Gut. 2018 Aug 21. pii: gutjnl-2018-316599. doi: 10.1136/gutjnl-2018-316599. [Epub ahead of print] No abstract available.

PMID:
30131321
19.

Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients.

Rompianesi G, Ravikumar R, Jose S, Allison M, Athale A, Creamer F, Gunson B, Manas D, Monaco A, Mirza D, Owen N, Roberts K, Sen G, Srinivasan P, Wigmore S, Fusai G, Fernando B, Burroughs A, Tsochatzis E.

Liver Int. 2018 Aug 20. doi: 10.1111/liv.13947. [Epub ahead of print]

PMID:
30129181
20.

Imaging in Autoimmune Pancreatitis and Immunoglobulin G4-Related Disease of the Abdomen.

Sandrasegaran K, Menias CO.

Gastroenterol Clin North Am. 2018 Sep;47(3):603-619. doi: 10.1016/j.gtc.2018.04.007. Epub 2018 Jul 7. Review.

PMID:
30115440

Supplemental Content

Loading ...
Support Center